Zhao is the chairman and president of Bloomage Biotechnology, a maker of medical skincare products. The Jinan, China-based company is publicly traded and reported revenue of 4.9 billion yuan ($767 million) in 2021. Its products include hyaluronic acid, which is used by dermatologists to improve skin hydration.
Zhao Yan's net worth of $5.41B can buy ...
... and is equivalent to ...
The majority of Zhao's fortune is derived from her stake in Bloomage Biotechnology Corp, a publicly traded maker of medical skincare products.
She owns about 59% of the shares in Bloomage BioTech, according to the company's 2022 third-quarter report.
She also holds about a 7% stake in First Capital Securities, a Shenzhen-based provider of financial services. About two-fifths of the shares are pledged and removed from the calculation, according to a Nov. 4, 2022 filing.
Cash investments are based on an analysis of dividends, insider transactions, taxes and market performance.
Jiang Rui, a spokesperson for Bloomage BioTech, declined to comment on the net worth calculation.
Zhou Yan has a bachelor's degree from East China Normal University. She completed an MBA in China between 2000 and 2002 at Peking University. Around the same time she also obtained an MBA from Fordham University in New York.
She joined the board of Shandong Freda Biopharmaceutic, later renamed Bloomage BioTech, in 2003 and was appointed chairman in 2019.